ARX517: it's still working while cohorts expand for mCRPC, with minimal side effects

[Maxone73]

targetedonc.com/view/arx517...

hopefully!

[KocoPr]

Amazing technology and results. A cure is coming soon!!!

[Maxone73 in reply to KocoPr]

Double crossing my fingers!

[ta1tanaka in reply to KocoPr]

The trial's estimated completion date is March 2027. 3 years and 3 months.

[Maxone73 in reply to ta1tanaka]

there are guys here that could access phase 1 and got results

[KocoPr in reply to Maxone73]

I would if i was running out of options

[Maxone73 in reply to KocoPr]

you can bet I would too!

[j-o-h-n in reply to Maxone73]

youtube.com/watch?v=dyZG1s7...(Not working as expected?)

Good Luck, Good Health and Good Humor.

j-o-h-n Wednesday 12/06/2023 11:27 AM EST

[KocoPr]

One really needs to do their homework when considering phase 1 trials that involve dose toxicity limits.